Stock Fundamentals

Company Information

▼
Company Name
Enanta Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US29251M1062
CIK: 0001177648
CUSIP: 29251M106
Currency: USD
Full Time Employees: 120
Phone: 617 607 0800
Website: https://www.enanta.com
Fiscal Year End: September
IPO Date: Mar 21, 2013
Description:

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Address:

4 Kingsbury Avenue, Watertown, MA, United States, 02472

Directors & Officers

▼
Name Title Year Born
Dr. Jay R. Luly Ph.D. President, CEO & Director 1956
Dr. Yat Sun Or Ph.D. Chief Scientific Officer 1952
Dr. Scott T. Rottinghaus M.D. Chief Medical Officer 1974
Mr. Harry R. Trout III VP of Finance & Interim Principal Financial Officer 1969
Ms. Kathleen S. Capps CPA Executive Director of Accounting, Controller & Interim Principal Accounting Officer 1985
Ms. Jennifer Viera Executive Director of Investor Relations & Corporate Communications NA
Mr. Matthew P. Kowalsky J.D. Chief Legal Officer & Corporate Secretary 1973
Mr. Nathaniel S. Gardiner J.D. Consultant 1954
Ms. Tara Lynn Kieffer Ph.D. Chief Product Strategy Officer 1978
Mr. Brendan Luu Chief Business Officer 1975

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Farallon Capital Management, L.L.C. 2.77M Dec 31, 2025 9.55% $0.21 30.63%
Krensavage Asset Management, LLC 2.77M Dec 31, 2025 9.53% $15.41 30.83%
Vanguard Group Inc 2.30M Dec 31, 2025 7.93% $0.00 18.72%
HHG PLC 1.95M Sep 30, 2025 6.71% $0.01 271.73%
BlackRock Inc 1.83M Sep 30, 2025 6.32% $0.00 -0.75%
Millennium Management LLC 948.08K Sep 30, 2025 3.27% $0.00 -35.00%
Acadian Asset Management LLC 867.04K Sep 30, 2025 2.99% $0.02 5,878.33%
COMMODORE CAPITAL LP 800.00K Sep 30, 2025 2.76% $0.47 0.00%
Renaissance Technologies Corp 642.20K Dec 31, 2025 2.21% $0.02 33.90%
Geode Capital Management, LLC 493.19K Sep 30, 2025 1.70% $0.00 1.52%
State Street Corp 471.99K Sep 30, 2025 1.63% $0.00 0.37%
Hillsdale Investment Management Inc. 422.30K Dec 31, 2025 1.46% $0.18 0.00%
Point72 Asset Management, L.P. 300.00K Sep 30, 2025 1.03% $0.01 0.00%
Two Sigma Investments LLC 285.45K Dec 31, 2025 0.98% $0.01 370.09%
Morgan Stanley - Brokerage Accounts 282.63K Sep 30, 2025 0.97% $0.00 -1.36%
Marshall Wace Asset Management Ltd 275.39K Sep 30, 2025 0.95% $0.00 -67.88%
JPMorgan Chase & Co 247.63K Sep 30, 2025 0.85% $0.00 89.86%
AQR Capital Management LLC 226.85K Sep 30, 2025 0.78% $0.00 -42.73%
Charles Schwab Investment Management Inc 218.64K Dec 31, 2025 0.75% $0.00 31.28%
Dimensional Fund Advisors, Inc. 211.61K Dec 31, 2025 0.73% $0.00 -21.64%

Shares Statistics

▼
Shares Outstanding: 29.02M
Shares Float: 20.20M
% Insiders: 469.40%
% Institutions: 9,148.90%
Short % Float: 9.39%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Farallon Capital Management, L.L.C. 2.77M 9.55% ▲ 30.63% Dec 31, 2025
2 Krensavage Asset Management, LLC 2.77M 9.53% ▲ 30.83% Dec 31, 2025
3 Vanguard Group Inc 2.30M 7.93% ▲ 18.72% Dec 31, 2025
4 HHG PLC 1.95M 6.71% ▲ 271.73% Sep 30, 2025
5 BlackRock Inc 1.83M 6.32% ▼ 0.75% Sep 30, 2025
6 Millennium Management LLC 948.08K 3.27% ▼ 35.00% Sep 30, 2025
7 Acadian Asset Management LLC 867.04K 2.99% ▲ 5,878.33% Sep 30, 2025
8 COMMODORE CAPITAL LP 800.00K 2.76% ▲ 0.00% Sep 30, 2025
9 Renaissance Technologies Corp 642.20K 2.21% ▲ 33.90% Dec 31, 2025
10 Geode Capital Management, LLC 493.19K 1.70% ▲ 1.52% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $286.20M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $414.98M
EBITDA: $-68.13M
PEG Ratio: $0.00
Book Value: $4.36
Earnings/Share: $-3.21
Profit Margin: -106.80%
Operating Margin: -60.45%
ROA (TTM): -13.47%
ROE (TTM): -60.01%
Revenue (TTM): $66.98M
Revenue/Share (TTM): $2.89
Earnings Growth (YOY): -66.20%
Revenue Growth (YOY): 9.80%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-09-30 4.21x 0.52x 0.77x -11.11x -0.48x
2024-09-30 5.21x 0.28x 0.66x -11.12x -0.34x
2023-09-30 6.73x 0.19x 0.53x -26.65x -0.33x
2022-09-30 10.45x 0.02x 0.16x -78.73x -0.05x
2021-09-30 8.82x 0.02x 0.09x -20.57x -0.08x
2020-09-30 18.08x 0.01x 0.07x -4.06x -0.11x
2019-09-30 17.77x 0.00x 0.06x 4.17x 0.04x
2018-09-30 23.74x 0.00x 0.05x 18.20x 0.02x
2017-09-30 11.33x 0.00x 0.08x 615.35x 0.03x
2016-09-30 29.43x 0.00x 0.04x 685.36x 0.01x
2015-09-30 25.45x 0.00x 0.04x 15,518.50x 0.00x
2014-09-30 22.75x 0.00x 0.04x 1,054.72x 0.01x
2013-09-30 23.14x 0.00x 0.06x 291.26x 0.00x
2012-09-30 8.25x 0.00x 0.16x N/A 0.00x
2011-09-30 11.68x 0.00x 6.06x 8.00x 0.00x
2010-09-30 N/A N/A N/A N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 05, 2025 Brendan Luu N/A Sale 1.39K $14.23 $19.84K
Dec 05, 2025 Jay R Luly N/A Sale 4.74K $14.23 $67.49K
Dec 05, 2025 Kathleen S Capps N/A Sale 323.00 $14.23 $4.60K
Dec 05, 2025 Scott T Rottinghaus N/A Sale 798.00 $14.23 $11.36K
Dec 05, 2025 Tara Lynn Kieffer N/A Sale 2.11K $14.23 $29.97K
Dec 05, 2025 Yat Sun Or N/A Sale 2.39K $14.23 $34.01K
Dec 02, 2025 Kathleen S Capps N/A Sale 207.00 $13.96 $2.89K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ENTA.US!